# Croma-Pharma GmbH: Observational study completed, 71 enrolled (Lateral Canthal Lines (LCL), Perioral Rhytids)

**Score:** 75/100

| Field | Value |
|---|---|
| Sponsor | Croma-Pharma GmbH |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | A Non-Interventional PMCF Study Evaluating Croma Revitalis for the Correction of Fine Lines |
| NCT ID | NCT07492277 |
| Phase | Observational |
| Status | completed |
| Conditions | Lateral Canthal Lines (LCL); Perioral Rhytids |
| Target enrollment | 71 |
| Site countries | Austria |
| Posted | 2026-03-25 |
| Planned start | 2026-01-16 |
| Event | Completed |
| Event date | 2026-10-01 |
| Last update posted | 2026-11-03 |

## Why this score
- Posted in the last two weeks.
- Industry sponsor (buys outsourced services).
- Completed: closeout, analysis and the next study ahead.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07492277). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.